Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets

Journal of Molecular Medicine

Volumn 85, Issue 3, 2007, Pages 253-267

  Wittchen, F ^a   Suckau, L ^a   Witt, H ^a   Skurk, C ^a   Lassner, D ^a   Fechner, H ^a   Sipo, I ^a   Ungethum U ^a   Ruiz, P ^a   Pauschinger, M ^a   Tschope, C ^a   Rauch, U ^a   Kuhl U ^a   Schultheiss, H P ^a   Poller, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Dilated cardiomyopathy; Genomic expression profiling; Heart failure; Human inflammatory cardiomyopathy; Molecular pathomechanisms; Molecular therapeutic targets

Indexed keywords

ADIPONECTIN; CYSTEINE RICH PROTEIN 61; INTERLEUKIN 27; TRANSCRIPTION FACTOR NFAT; CYR61 PROTEIN, HUMAN; CYTOKINE; IMMEDIATE EARLY PROTEIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ADIPONECTIN GENE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYSTEINE RICH PROTEIN 61 GENE; GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETICS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; PATHOGENESIS; BIOLOGICAL MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENOME; HEART MUSCLE CELL; METABOLISM; MIDDLE AGED;

ADIPONECTIN; ADULT; AGED; CARDIOMYOPATHY, DILATED; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENOME, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC;

EID: 33847121668     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0122-9     Document Type: Article

References (59)

1. Poller W, Kühl U, Tschoepe C, Pauschinger M, Fechner H, Schultheiss H-P (2005) Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Mol Med 83:579-586
2. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss H-P (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with " Idiopathic" left ventricular dysfunction. Circulation 111:887-893
3. Kühl U, Pauschinger M, Seeberg B, Noutsias M, Poller W, Schultheiss H-P (2005) Virus persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965-1970
4. Kühl U, Pauschinger M, Schwimmbeck P, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss H-P (2003) Interferon-β treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793-2798
5. Sanoudou D, Vafiadaki E, Arvanitis DA, Kranias E, Kontrogianni- Konstantopoulos A (2005) Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies. Physiol Genomics 21:131-143
6. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-408
7. Vetter R, Kott M, Schulze W, Rupp H (1998) Influence of different culture conditions on sarcoplasmic reticular calcium transport in isolated neonatal rat cardiomyocytes. Mol Cell Biochem 188:177-185
8. Verducci JS, Melfi VF, Lin S, Wang Z, Roy S, Sen CK (2006) Microarray analysis of gene expression: considerations in data mining and statistical treatment. Physiol Genomics 25:355-363
9. Jin Y, Kim HP, Ifedigbo E, Lau LF, Choi AM (2005) Cyr61 protects against hyperoxia-induced cell death via Akt pathway in pulmonary epithelial cells. Am J Respir Cell Mol Biol 33:297-302
10. Kobashi C, Urakaze M, Kishida M, Kibayashi E, Kobayashi H, Kihara S, Funahashi T, Takata M, Temaru R, Sato A, Yamazaki K, Nakamura N, Kobayashi M (2005) Adiponectin inhibits endothelial synthesis of interleukin-8. Circ Res 97:1245-1252. See also related comment by Touyz RM, Circ Res 97:1216-1219
11. Kim HB, Kong M, Kim TM, Suh YH, Kim WH, Lim JH, Song JH, Jung MH (2006) NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes. Diabetes 55:1342-1352
12. Kim KY, Kim JK, Han SH, Lim JS, Kim KI, Cho DH, Lee MS, Lee JH, Yoon DY, Yoon SR, Chung JW, Choi I, Kim E, Yang Y (2006) Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol 176:5958-5964
13. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, Jiang W, Luo X, Li X, Yin H, Montag AG, Haydon RC, He TC (2006) CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26:2955-2964
14. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P (2006) Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (London) 110:267-278
15. Kaynak B, von Heydebreck A, Mebus S, Seelow D, Hennig S, Vogel J, Sperling HP, Pregla R, Alexi-Meskishvili V, Hetzer R, Lange PE, Vingron M, Lehrach H, Sperling S (2003) Genome-wide array analysis of normal and malformed human hearts. Circulation 107:2467-2474
16. Sharma UC, Pokharel S, Evelo CT, Maessen JG (2005) A systematic review of large scale and heterogeneous gene array data in heart failure. J Mol Cell Cardiol 38:425-432
17. Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, Mitchell CA, Young JB, Francis GS, McCarthy PM, Bond M (2000) Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102:3046-3052
18. Tan FL, Moravec CS, Li J, Apperson-Hansen C, McCarthy PM, Young JB, Bond M (2002) The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 99:11387-11392
19. Grzeskowiak R, Witt H, Drungowski M, Thermann R, Hennig S, Perrot A, Osterziel KJ, Klingbiel D, Scheid S, Spang R, Lehrach H, Ruiz P (2003) Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 59:400-411
20. Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, Conte JV, Parmigiani G, Miller LW, Chen Y, Hall JL, Garcia JG, Hare JM (2004) Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110:3444-3451
21. Yung CK, Halperin VL, Tomaselli GF, Winslow RL (2004) Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 83:281-297
22. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, Conte JV, Tomaselli G, Garcia JG, Hare JM (2005) Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21:299-307
23. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, Bednarik D (2005) Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 96:592-599
24. Beisvag V, Lehre PK, Midelfart H, Aass H, Geiran O, Sandvik AK, Laegreid A, Komorowski J, Ellingsen O (2006) Aetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data. Eur J Heart Fail 8:381-389
25. Lowes BD, Zolty R, Minobe WA, Robertson AD, Leach S, Hunter L, Bristow MR (2006) Serial gene expression profiling in the intact human heart. J Heart Lung Transplant 25:579-588
26. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, Conte JV, Tomaselli G, Garcia JG, Hare JM (2005) Gene expression in giant cell myocarditis: altered expression of immune response genes. Int J Cardiol 102:333-340
27. Perbal B (2004) CCN proteins: multifunctional signalling regulators. Lancet 363:62-64
28. Todorovic V, Chen CC, Hay N, Lau LF (2005) The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J Cell Biol 171:559-568
29. Kim KH, Min YK, Baik JH, Lau LF, Chaqour B, Chung KC (2003) Expression of angiogenic factor Cyr61 during neuronal cell death via the activation of c-Jun N-terminal kinase and serum response factor. J Biol Chem 278:13847-13854
30. Kim SM, Park JH, Chung SK, Kim JY, Hwang HY, Chung KC, Jo I, Park SI, Nam JH (2004) Coxsackie virus B3 infection induces cyr61 activation via JNK to mediate cell death. J Virol 78:13479-13488
31. Chen CC, Mo FE, Lau LF (2001) The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276:47329-47337
32. Nguyen N, Kuliopulos A, Graham RA, Covic L (2006) Tumor-derived Cyr61 (CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. Cancer Res 66:2658-2665
33. Grzeszkiewicz TM, Lindner V, Chen N, Lam SC, Lau LF (2002) The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin α6β1 and cell surface heparan sulfate proteoglycans. Endocrinology 143:1441-1450
34. Grzeszkiewicz TM, Kirschling DJ, Chen N, Lau LF (2001) CYR61 stimulates human skin fibroblast migration through Integrin αvβ5 and enhances mitogenesis through integrin αvβ3, independent of its carboxyl-terminal domain. J Biol Chem 276:21943-21950
35. Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SC (2002) Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 99:4457-4465
36. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP (2004) Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 64:1987-1996
37. Hilfiker-Kleiner D, Kaminski K, Kaminska A, Fuchs M, Klein G, Podewski E, Grote K, Kiian I, Wollert KC, Hilfiker A, Drexler H (2004) Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 109:2227-2233
38. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, Kumada M, Sato K, Schiekofer S, Ohashi K, Funahashi T, Colucci WS, Walsh K (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10:1384-1389
39. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11:1096-1103. See also related comment by Yuhki K et al, Nat Med 11:1048-1049
40. Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, Dieguez C, Gualillo O, Gonzalez-Juanatey JR, Lago F (2005) Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 579:5163-5169
41. Nian M, Lee P, Khaper N, Liu P (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94:1543-1553
42. Prabhu SD (2004) Cytokine-induced modulation of cardiac function. Circ Res 95:1140-1153
43. Pisabarro MT, Leung B, Kwong M, Corpuz R, Frantz GD, Chiang N, Vandlen R, Diehl LJ, Skelton N, Kim HS, Eaton D, Schmidt KN (2006) Cutting edge: novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methods. J Immunol 176:2069-2073
44. Schaerli P, Willimann K, Ebert LM, Walz A, Moser B (2005) Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23:331-342
45. Shurin GV, Ferris R, Tourkova IL, Perez L, Lokshin A, Balkir L, Collins B, Chatta GS, Shurin MR (2005) Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 174:5490-5498
46. Vargas-Leal V, Bruno R, Derfuss T, Krumbholz M, Hohlfeld R, Meinl E (2005) Expression and function of glial cell line-derived neurotrophic factor family ligands and their receptors on human immune cells. J Immunol 175:2301-2308
47. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467-476
48. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R (2002) Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 169:642-646
49. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL (2004) Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 279:2559-2567
50. Takahashi H, Numasaki M, Lotze MT, Sasaki H (2005) Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett 98:189-193
51. Prause O, Bozinovski S, Anderson GP, Linden A (2004) Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 59:313-317
52. Hite R, Seeds M, Safta A, Jacinto R, Gyves J, Bass D, Waite B (2004) Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A2-mediated surfactant dysfunction. Am J Physiol-Lung Cell Mol Physiol 288:L618-L624
53. Jo E, Lee H-Y, Lee Y-N, Kim J, Kang H-K, Park D-W, Baek S-H, Kwak J-Y, Bae Y-S (2004) Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-κB in human neutrophils. J Immunol 173:6433-6439
54. Noutsias M, Seeberg B, Schultheiss H, Kuhl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99:2124-2131
55. 5 on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy-implications for cardiotropic viral infections. Circulation 104:275-280
56. Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5:472-484
57. Inagaki K, Fuess S, Storm TA, Gibson GA, McTiernan CF, Kay MA, Nakai H (2006) Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Molec Ther 14:45-53
58. Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J, Chen C, Li J, Xiao X (2005) Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23:321-328
59. Fechner H, Suckau L, Kurreck J, Sipo I, Wang X, Pinkert S, Loschen S, Rekittke J, Weger S, Dekkers D, Vetter R, Erdmann VA, Schultheiss H-P, Paul M, Lamers J, Poller W (2006) Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban. Gene Ther advance online publication, October 5 (in press)